Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 342

1.

Association of blood group A with early-onset ovarian hyperstimulation syndrome.

Binder H, Flegel WA, Emran J, Müller A, Dittrich R, Beckmann MW, Zingsem J, Eckstein R, Ringwald J.

Transfus Clin Biol. 2008 Dec;15(6):395-401. doi: 10.1016/j.tracli.2008.06.002. Epub 2008 Aug 30.

PMID:
18757223
2.

Blood group A: an overseen risk factor for early-onset ovarian hyperstimulation syndrome?

Binder H, Flegel WA, Emran J, Müller A, Cupisti S, Beckmann MW, Eckstein R, Dittrich R, Ringwald J.

Reprod Biomed Online. 2008 Aug;17(2):185-9.

PMID:
18681991
4.

Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.

Pau E, Alonso-Muriel I, Gómez R, Novella E, Ruiz A, García-Velasco JA, Simón C, Pellicer A.

Hum Reprod. 2006 Jun;21(6):1453-60. Epub 2006 Feb 17.

PMID:
16488907
5.
6.

[Pituitary down-regulation and ovulation stimulation with gradually increased gonadotropin in controlled ovarian hyperstimulation].

Zhu L, Song YL, Cui YG, Xing FQ.

Nan Fang Yi Ke Da Xue Xue Bao. 2007 Mar;27(3):361-3. Chinese.

7.

Efficacy of metformin supplementation during ovarian stimulation of lean PCOS patients undergoing in vitro fertilization.

Kumbak B, Kahraman S.

Acta Obstet Gynecol Scand. 2009;88(5):563-8. doi: 10.1080/00016340902835919.

PMID:
19306135
8.

Follicle-stimulating hormone receptor polymorphism (Thr307Ala) is associated with variable ovarian response and ovarian hyperstimulation syndrome in Indian women.

Achrekar SK, Modi DN, Desai SK, Mangoli VS, Mangoli RV, Mahale SD.

Fertil Steril. 2009 Feb;91(2):432-9. doi: 10.1016/j.fertnstert.2007.11.093. Epub 2008 Mar 5.

PMID:
18321487
9.

Management and obstetric outcome of ovarian hyperstimulation syndrome.

Zareen N.

J Coll Physicians Surg Pak. 2008 Feb;18(2):86-90. doi: 02.2008/JCPSP.8690.

PMID:
18454892
10.

Two cases of cholestasis in the first trimester of pregnancy after ovarian hyperstimulation.

Zamah AM, El-Sayed YY, Milki AA.

Fertil Steril. 2008 Oct;90(4):1202.e7-10. doi: 10.1016/j.fertnstert.2007.08.072.

PMID:
18929050
11.

Blood group and ovarian hyperstimulation syndrome.

Bellver J, Ferrando M, Garrido N, Pellicer A.

Fertil Steril. 2010 Jan;93(1):270-1. doi: 10.1016/j.fertnstert.2009.07.983. Epub 2009 Aug 14.

PMID:
19683228
12.

Adverse effects of excessive ovarian response on the pregnancy rate of in vitro fertilization treatment.

Ng EH.

Gynecol Endocrinol. 2009 Jan;25(1):2-7. doi: 10.1080/09513590802296237. Review. No abstract available.

PMID:
19165656
13.

Thrombophilia and ovarian hyperstimulation syndrome: a case report.

Levy G, Lucidi RS.

Hawaii Med J. 2011 May;70(5):97-8.

14.

Update on ovarian hyperstimulation syndrome: part 2--clinical signs and treatment.

Binder H, Dittrich R, Einhaust F, Krieg J, Müller A, Strauss R, Beckmann MW, Cupisti S.

Int J Fertil Womens Med. 2007 Mar-Jun;52(2-3):69-81. Review.

PMID:
18320864
15.

Odds of ovarian hyperstimulation syndrome (OHSS) - time for reassessment.

Mocanu E, Redmond ML, Hennelly B, Collins C, Harrison R.

Hum Fertil (Camb). 2007 Sep;10(3):175-81.

PMID:
17786650
16.
17.

[Some aspects of ovarian hyperstimulation syndrome].

Kovachev E, Kozovski I, Markova V, Andronov M, Cherneva S, Aleksandrov K.

Akush Ginekol (Sofiia). 2003;42(6):37-41. Review. Bulgarian.

PMID:
15067814
18.

Risk of thromboembolism in relation to an in-vitro fertilization programme: three case reports.

Aurousseau MH, Samama MM, Belhassen A, Herve F, Hugues JN.

Hum Reprod. 1995 Jan;10(1):94-7. Review.

PMID:
7745079
19.

Ovarian hyperstimulation syndrome: definition, incidence, and classification.

Zivi E, Simon A, Laufer N.

Semin Reprod Med. 2010 Nov;28(6):441-7. doi: 10.1055/s-0030-1265669. Epub 2010 Nov 16. Review.

PMID:
21082501
20.

Severity of ovarian hyperstimulation syndrome: its relation to number of conceptuses.

Koike T, Minakami H, Araki S, Sayama M, Matsubara S, Suzuki M.

Int J Fertil Womens Med. 2004 Jan-Feb;49(1):36-42.

PMID:
15038508

Supplemental Content

Support Center